{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:21:23Z","timestamp":1791426083143,"version":"4.3.3"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.therap.2016.02.001","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T14:32:05Z","timestamp":1458311525000},"page":"307-313","source":"Crossref","is-referenced-by-count":9,"title":["Caract\u00e9ristiques des sujets sous traitement de substitution vus en m\u00e9decine g\u00e9n\u00e9rale d\u2019apr\u00e8s l\u2019enqu\u00eate nationale OPEMA 2013"],"prefix":"10.1016","volume":"71","author":[{"given":"Ga\u00ebtan","family":"Gentile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Frauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Giocanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronica","family":"Orleans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Amaslidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Thirion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2016.02.001_bib0135","series-title":"Les traitements de substitution aux opiac\u00e9s en France\u00a0: donn\u00e9es r\u00e9centes","author":"ANSM","year":"2014"},{"issue":"2","key":"10.1016\/j.therap.2016.02.001_bib0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2515\/therapie\/2013020","article-title":"New formulation of methadone for opioid dependence in France: acceptability and diversion\/misuse liability","volume":"68","author":"Eiden","year":"2013","journal-title":"Therapie"},{"issue":"3","key":"10.1016\/j.therap.2016.02.001_bib0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2515\/therapie\/2010012","article-title":"La bupr\u00e9norphine pour le traitement de la d\u00e9pendance aux opiac\u00e9s\u00a0: une \u00e9tude sur la substitution par les g\u00e9n\u00e9riques men\u00e9e en pharmacie d\u2019officine","volume":"65","author":"Julians-Minou","year":"2010","journal-title":"Therapie"},{"issue":"2","key":"10.1016\/j.therap.2016.02.001_bib0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2515\/therapie\/2012011","article-title":"Taux de p\u00e9n\u00e9tration des g\u00e9n\u00e9riques de la bupr\u00e9norphine haut dosage\u00a0: principales tendances de 2006\u00a0\u00e0 2008","volume":"67","author":"Boczek","year":"2012","journal-title":"Therapie"},{"issue":"3","key":"10.1016\/j.therap.2016.02.001_bib0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2515\/therapie\/2013022","article-title":"Cycles de traitement par m\u00e9dicament de substitution aux opiac\u00e9s dans une cohorte de patients suivis 5ans en m\u00e9decine ambulatoire","volume":"68","author":"Dupouy","year":"2013","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2016.02.001_bib0160","series-title":"D\u00e9cret no\u00a02014-322\u00a0du 11\u00a0mars 2014\u00a0relatif \u00e0 la mission interminist\u00e9rielle de lutte contre les drogues et les conduites addictives","year":"2014"},{"issue":"3","key":"10.1016\/j.therap.2016.02.001_bib0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2515\/therapie\/2011045","article-title":"Les syst\u00e8mes d\u2019\u00e9valuation de l\u2019abus et de la d\u00e9pendance des m\u00e9dicaments psychoactifs","volume":"66","author":"Nordmann","year":"2011","journal-title":"Therapie"},{"issue":"4","key":"10.1016\/j.therap.2016.02.001_bib0170","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2515\/therapie\/2012037","article-title":"Observation des pharmacod\u00e9pendances en m\u00e9decine ambulatoire\u00a0: le programme OPEMA","volume":"67","author":"Moracchini","year":"2012","journal-title":"Therapie"},{"issue":"6","key":"10.1016\/j.therap.2016.02.001_bib0175","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2515\/therapie:2004100","article-title":"Utilisation des bases de donn\u00e9es de l\u2019Assurance maladie par les centres d\u2019\u00e9valuation et d\u2019information sur la pharmacod\u00e9pendance\u00a0: exemples, int\u00e9r\u00eats et perspectives","volume":"59","author":"Micallef","year":"2004","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2016.02.001_bib0180","series-title":"R\u00e9sultats enqu\u00eate 1\u00a0OPEMA\u00a0\u2013\u00a0d\u00e9cembre 2009\u00a0Afssaps CEIP (centres d\u2019\u00e9valuation et d\u2019information sur la pharmacod\u00e9pendance) OPEMA (observation des pharmacod\u00e9pendances en m\u00e9decine ambulatoire)","author":"Afssaps","year":"2010"},{"key":"10.1016\/j.therap.2016.02.001_bib0185","series-title":"R\u00e9sultats enqu\u00eate 2\u00a0OPEMA\u00a0\u2013\u00a0d\u00e9cembre 2009\u00a0Afssaps CEIP (centres d\u2019\u00e9valuation et d\u2019information sur la pharmacod\u00e9pendance) OPEMA (observation des pharmacod\u00e9pendances en m\u00e9decine ambulatoire)","author":"Afssaps","year":"2011"},{"key":"10.1016\/j.therap.2016.02.001_bib0190","series-title":"Centres d\u2019\u00e9valuation et d\u2019information sur la pharmacod\u00e9pendance (CEIP) OPEMA (observation des pharmacod\u00e9pendances en m\u00e9decine ambulatoire). R\u00e9sultats enqu\u00eate 3\u00a0OPEMA","author":"ANSM","year":"2010"},{"key":"10.1016\/j.therap.2016.02.001_bib0195","series-title":"Centres d\u2019\u00e9valuation et d\u2019information sur la pharmacod\u00e9pendance (CEIP) OPEMA (observation des pharmacod\u00e9pendances en m\u00e9decine ambulatoire). R\u00e9sultats enqu\u00eate 4\u00a0OPEMA","author":"ANSM","year":"2012"},{"issue":"1\u20133","key":"10.1016\/j.therap.2016.02.001_bib0200","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.drugalcdep.2008.07.017","article-title":"Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence","volume":"99","author":"Lavie","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.therap.2016.02.001_bib0205","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2515\/therapie\/2009051","article-title":"Second meeting of the French CEIP (centres d\u2019\u00e9valuation et d\u2019information sur la pharmacod\u00e9pendance). Part II: benzodiazepine withdrawal","volume":"64","author":"Authier","year":"2009","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2016.02.001_bib0210","first-page":"49","article-title":"Douleur et addiction aux opiac\u00e9s","volume":"9","author":"Authier","year":"2007","journal-title":"Courrier Addict"},{"key":"10.1016\/j.therap.2016.02.001_bib0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1744-8069-3-25","article-title":"Neuroimaging revolutionizes therapeutic approaches to chronic pain","volume":"3","author":"Borsook","year":"2007","journal-title":"Mol Pain"},{"key":"10.1016\/j.therap.2016.02.001_bib0220","unstructured":"Plan gouvernemental de lutte contre les drogues et les toxicomanies 2008\u20132011\u00a0MILDT. 2008. http:\/\/www.drogues.gouv.fr\/sites\/drogues.gouv.fr\/files\/atoms\/files\/plan_gouvernemental_2008-2011-fre.pdf [consult\u00e9 le 12\u00a0novembre 2015 (112\u00a0pp.)]."},{"issue":"4","key":"10.1016\/j.therap.2016.02.001_bib0225","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0755-4982(06)74647-4","article-title":"Sevrage aux benzodiaz\u00e9pines des sujets d\u00e9pendants aux opiac\u00e9s en traitement de substitution","volume":"35","author":"Fats\u00e9as","year":"2006","journal-title":"Presse Med"},{"issue":"5","key":"10.1016\/j.therap.2016.02.001_bib0230","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2515\/therapie\/2012064","article-title":"Les CAARUD, lieux privil\u00e9gi\u00e9s d\u2019\u00e9mergence de signaux pour l\u2019addictovigilance","volume":"67","author":"Moracchini","year":"2012","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2016.02.001_bib0235","series-title":"La d\u00e9finition europ\u00e9enne de la m\u00e9decine g\u00e9n\u00e9rale-m\u00e9decine de famille","author":"Wonca Europe","year":"2002"},{"issue":"3","key":"10.1016\/j.therap.2016.02.001_bib0240","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2515\/therapie\/2014032","article-title":"Utilisation des g\u00e9n\u00e9riques de la bupr\u00e9norphine haut dosage (BHD)\u00a0: \u00e9valuation qualitative","volume":"69","author":"El-Ha\u00efk","year":"2014","journal-title":"Therapie"},{"issue":"6","key":"10.1016\/j.therap.2016.02.001_bib0245","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2515\/therapie\/2009054","article-title":"Association des CEIP Second meeting of the French CEIP (Centres d\u2019\u00e9valuation et d\u2019information sur la pharmacod\u00e9pendance). Part I: how to evaluate and prevent the abuse and dependence on hypnotic\/anxiolytic drugs?","volume":"64","author":"Micallef-Roll","year":"2009","journal-title":"Therapie"},{"issue":"4","key":"10.1016\/j.therap.2016.02.001_bib0250","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2515\/therapie\/2009043","article-title":"Comparison between analytic and anamnestic data about drug consumption among opiate addicts with substitutes therapy. A feasibility study","volume":"64","author":"Bourgine","year":"2009","journal-title":"Therapie"},{"issue":"4","key":"10.1016\/j.therap.2016.02.001_bib0255","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000336540","article-title":"On-site drugs of abuse urinary screening tests for the management of opiate-addicted patients: a survey among French general practitioners","volume":"18","author":"Dupouy","year":"2012","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.therap.2016.02.001_bib0130","unstructured":"On-site evaluation of substances consumption on opiate maintenance\u00a0\u2013\u00a0View-ClinicalTrials.gov. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02345655 [consult\u00e9 le 12\u00a0novembre 2015 (1\u00a0page)]."}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716000160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716000160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T11:51:56Z","timestamp":1554292316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716000160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0040595716000160"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2016.02.001","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}